201 related articles for article (PubMed ID: 21494092)
1. Establishment and characterization of Prnp knockdown neuroblastoma cells using dual microRNA-mediated RNA interference.
Kang SG; Roh YM; Lau A; Westaway D; McKenzie D; Aiken J; Kim YS; Yoo HS
Prion; 2011; 5(2):93-102. PubMed ID: 21494092
[TBL] [Abstract][Full Text] [Related]
2. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of prion protein (PrP) by RNA interference weakens the protective activity of wild-type PrP against copper ion and antagonizes the cytotoxicity of fCJD-associated PrP mutants in cultured cells.
Wang ZY; Tian C; Jing YY; Gong HS; Guo Y; Shi Q; Chen C; Zhu SY; Dong XP
Int J Mol Med; 2011 Sep; 28(3):413-21. PubMed ID: 21537833
[TBL] [Abstract][Full Text] [Related]
4. Prnp knockdown in transgenic mice using RNA interference.
Gallozzi M; Chapuis J; Le Provost F; Le Dur A; Morgenthaler C; Peyre C; Daniel-Carlier N; Pailhoux E; Vilotte M; Passet B; Herzog L; Beringue V; Costa J; Tixador P; Tilly G; Laude H; Vilotte JL
Transgenic Res; 2008 Oct; 17(5):783-91. PubMed ID: 18350371
[TBL] [Abstract][Full Text] [Related]
5. Prions: pathogenesis and reverse genetics.
Aguzzi A; Klein MA; Montrasio F; Pekarik V; Brandner S; Furukawa H; Käser P; Röckl C; Glatzel M
Ann N Y Acad Sci; 2000; 920():140-57. PubMed ID: 11193143
[TBL] [Abstract][Full Text] [Related]
6. Biology of the prion gene complex.
Mastrangelo P; Westaway D
Biochem Cell Biol; 2001; 79(5):613-28. PubMed ID: 11716303
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
Kumar R; McClain D; Young R; Carlson GA
J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of the bovine prion gene PRNP by RNA interference (RNAi) technology.
Sutou S; Kunishi M; Kudo T; Wongsrikeao P; Miyagishi M; Otoi T
BMC Biotechnol; 2007 Jul; 7():44. PubMed ID: 17655742
[TBL] [Abstract][Full Text] [Related]
9. Mouse neuronal cells expressing exogenous bovine PRNP and simultaneous downregulation of endogenous mouse PRNP using siRNAs.
Kang SG; Roh YM; Kang ML; Kim YS; Yoo HS
Prion; 2010; 4(1):32-7. PubMed ID: 20215868
[TBL] [Abstract][Full Text] [Related]
10. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of specific protein 1 (SP1) by hypoxia-inducible factor 1 alpha (HIF-1α) leads to PRNP expression and neuroprotection from toxic prion peptide.
Jeong JK; Park SY
Biochem Biophys Res Commun; 2012 Dec; 429(1-2):93-8. PubMed ID: 23131565
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial localization of cellular prion protein (PrPC) invokes neuronal apoptosis in aged transgenic mice overexpressing PrPC.
Hachiya NS; Yamada M; Watanabe K; Jozuka A; Ohkubo T; Sano K; Takeuchi Y; Kozuka Y; Sakasegawa Y; Kaneko K
Neurosci Lett; 2005 Feb; 374(2):98-103. PubMed ID: 15644272
[TBL] [Abstract][Full Text] [Related]
13. Loss of Cellular Sialidases Does Not Affect the Sialylation Status of the Prion Protein but Increases the Amounts of Its Proteolytic Fragment C1.
Katorcha E; Klimova N; Makarava N; Savtchenko R; Pan X; Annunziata I; Takahashi K; Miyagi T; Pshezhetsky AV; d'Azzo A; Baskakov IV
PLoS One; 2015; 10(11):e0143218. PubMed ID: 26569607
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
Bate C; Tayebi M; Diomede L; Salmona M; Williams A
BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetics of transmissible spongiform encephalopathies: an introduction.
Weissmann C
J Toxicol Sci; 2002 May; 27(2):69-77. PubMed ID: 12058449
[TBL] [Abstract][Full Text] [Related]
16. Prions mediated neurodegenerative disorders.
Huang WJ; Chen WW; Zhang X
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4028-34. PubMed ID: 26592824
[TBL] [Abstract][Full Text] [Related]
17. Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis, and death: Role of AMPA/kainate receptors.
Rangel A; Burgaya F; Gavín R; Soriano E; Aguzzi A; Del Río JA
J Neurosci Res; 2007 Sep; 85(12):2741-55. PubMed ID: 17304577
[TBL] [Abstract][Full Text] [Related]
18. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
[TBL] [Abstract][Full Text] [Related]
19. RNAi: a novel strategy for the treatment of prion diseases.
Kong Q
J Clin Invest; 2006 Dec; 116(12):3101-3. PubMed ID: 17143323
[TBL] [Abstract][Full Text] [Related]
20. Prion peptide-mediated cellular prion protein overexpression and neuronal cell death can be blocked by aspirin treatment.
Jeong JK; Moon MH; Seol JW; Seo JS; Lee YJ; Park SY
Int J Mol Med; 2011 May; 27(5):689-93. PubMed ID: 21347512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
